Scholarlink

Background <p>There is increasing evidence that microplastics exert harmful effects on human health and on the ocular surface. This pilot study aims to investigate if microplastic particles are present in commonly used eyedrops in single-use plastic vials.</p> Methods <p>Six commonly used commercial tear-replacement solutions available without a doctor’s prescription were tested (Brands A-F). All brands of eyedrops were analysed visually using light microscopy and the number of microplastic particles were manually counted. These were further analysed using the Agilent&#xa0;8700 Laser Direct Infrared (LDIR) chemical imaging system.</p> Results <p>All eyedrops analysed contained microplastics. The number of particles identified using light microscopy ranged between 15 (Brand E) to &gt;18,000 (Brand F). In total, nine types of microplastics were identified with LDIR – polyethylene, polypropylene, polystyrene, polyvinylchloride, polyethylene terephthalate, polycarbonate, polymethylmethacrylate, polyamide and polyurethane.</p> Conclusions <p>This study provides the most extensive quantification of microplastic contamination in commercial eyedrops to date, highlighting a major, under-recognised source of ocular exposure. These particles may arise&#xa0;from secondary degradation of plastic vials during production, transportation, storage, or during instillation, or&#xa0;introduced from other sources during production and represent a major source of exposure to the ocular surface, especially among patients who require chronic instillation of eyedrops.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Microplastics identified in commercial over-the-counter lubricant eyedrops

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Julia Jaeger,
  • Matthew Burke,
  • Duoduo Wu,
  • Emily Ern-Min Curren,
  • Sandric Chee Yew Leong,
  • Robert Symons,
  • Blanche Xiao Hong Lim,
  • Xinyi Su,
  • Jodhbir Singh Mehta,
  • Andri Kartasasmita Riau,
  • Chris Hong Long Lim

摘要

Background

There is increasing evidence that microplastics exert harmful effects on human health and on the ocular surface. This pilot study aims to investigate if microplastic particles are present in commonly used eyedrops in single-use plastic vials.

Methods

Six commonly used commercial tear-replacement solutions available without a doctor’s prescription were tested (Brands A-F). All brands of eyedrops were analysed visually using light microscopy and the number of microplastic particles were manually counted. These were further analysed using the Agilent 8700 Laser Direct Infrared (LDIR) chemical imaging system.

Results

All eyedrops analysed contained microplastics. The number of particles identified using light microscopy ranged between 15 (Brand E) to >18,000 (Brand F). In total, nine types of microplastics were identified with LDIR – polyethylene, polypropylene, polystyrene, polyvinylchloride, polyethylene terephthalate, polycarbonate, polymethylmethacrylate, polyamide and polyurethane.

Conclusions

This study provides the most extensive quantification of microplastic contamination in commercial eyedrops to date, highlighting a major, under-recognised source of ocular exposure. These particles may arise from secondary degradation of plastic vials during production, transportation, storage, or during instillation, or introduced from other sources during production and represent a major source of exposure to the ocular surface, especially among patients who require chronic instillation of eyedrops.